文献速递糖尿病

通过CD47激活调控胰岛应激反应

Regulating islet stress responses through CD47 activation.
PubMed 文献 · Diabetologia · 2025-03-25

研究利用CD47基因缺失的小鼠原代胰岛及药物阻断CD47信号的人胰岛和MIN6细胞,发现应激可上调CD47及其配体TSP1,限制CD47信号可改善衰老、凋亡、内质网应激等标志物并维持胰岛素分泌;老年和2型糖尿病供者胰岛及1型糖尿病患者胰腺中CD47表达增加。

要点

  • 应激刺激可显著上调胰岛CD47及其高亲和力配体TSP1的表达。
  • 限制CD47信号可改善衰老、凋亡、内质网应激等标志物并维持胰岛素分泌反应。
  • 老年和2型糖尿病供者内分泌胰腺中CD47与衰老标志物表达同步上调,1型糖尿病患者胰腺CD47和TSP1及血浆TSP1水平升高。

核心结论

  • CD47是胰岛功能障碍的新型调节因子,调控应激下的细胞保护反应,可能参与糖尿病发生中的β细胞损伤及胰岛移植后功能衰竭。
  • 限制CD47激活可能是胰岛功能不足时的潜在治疗工具。

研究设计与样本

  • 使用有或无CD47基因缺失的小鼠原代胰岛,以及经siRNA或阻断抗体药物干扰CD47信号的人胰岛和MIN6细胞。
  • 通过暴露于缺氧、高糖或毒胡萝卜素诱导细胞代谢应激,评估未折叠蛋白反应、细胞存活及胰岛素分泌功能标志物。
  • 检查有或无糖尿病个体的人胰腺中CD47信号证据。

主要发现

  • 外源性应激源可显著上调CD47及其高亲和力配体血小板反应蛋白-1(TSP1)的表达。
  • 限制CD47信号可改善衰老、凋亡、内质网应激、未折叠蛋白反应、自我更新和自噬的标志物,并维持胰岛素分泌反应。
  • 老年供者和2型糖尿病供者的内分泌胰腺中CD47与衰老标志物表达同步上调。
  • 1型糖尿病患者胰腺中CD47和TSP1表达增加,血浆TSP1水平亦升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Diabetes is a global health burden characterised by incremental beta cell loss. Islet transplantation is a recognised treatment for individuals with type 1 diabetes and hypoglycaemia unawareness but broader application is constrained by limited islet survival and function post-transplantation. The underlying molecular mechanisms that induce beta cell dysfunction and demise remain unclear, and therapeutic agents that protect against cellular loss and maintain insulin secretion are in demand as potential treatment options. CD47 is a cell surface protein implicated in cellular stress responses but its role in beta cell function remains relatively unexplored. We hypothesised that modulating CD47 expression would demonstrate a cytoprotective effect in beta cells. METHODS: We used primary murine islets with/without genetic deletion of CD47, as well as human islets and MIN6 cells subjected to pharmacological disruption of CD47 signalling (siRNA or blocking antibody). Metabolic stress was induced in cells by exposure to hypoxia, hyperglycaemia or thapsigargin, and markers of the unfolded protein response, cell survival and insulin secretory function were assessed. Human pancreases from individuals with and without diabetes were examined for evidence of CD47 signalling. RESULTS: Expression of CD47 and its high affinity ligand thrombospondin-1 (TSP1) was robustly upregulated by exogenous stressors. Limiting CD47 signalling improved markers of senescence, apoptosis, endoplasmic reticulum stress, unfolded protein response, self-renewal and autophagy, and maintained insulin secretory responses. We also found concurrent upregulated expression of CD47 and senescence markers in the endocrine pancreas of aged donors and those with type 2 diabetes. Both CD47 and TSP1 expression were increased in pancreases of humans with type 1 diabetes, as were plasma levels of TSP1. CONCLUSIONS/INTERPRETATION: Our study provides key insights into the essential role of CD47 as a novel regulator of islet dysfunction, regulating cytoprotective responses to stress. CD47 may contribute to beta cell damage during the development of diabetes and failure of islet transplant function. Therefore, limiting CD47 activation may be a potential therapeutic tool in conditions where islet function is inadequate.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Kale A, Azar M, Cheng V, et al. Regulating islet stress responses through CD47 activation. Diabetologia. 2025. PMID: 40133488. doi:10.1007/s00125-025-06409-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。